EGFR and non-small cell lung carcinoma: However, in breast cancer, prostate cancer, pancreatic cancer, gastric cancer, as well as in NSCLC cell lines, miR-146a-5p acted as a tumor suppressor through the targeting of Rac1/ROCK1/EGFR [16–25] (Figure 7).